Lawrence Otto Klein Jasper Therapeutics, Inc. (JSPR) insider trading activity

Lawrence Otto Klein is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 24,500 shares of JSPR, which is worth approximately $545,125. The most recent transaction as insider was on Oct 12, 2022, when has been sold 24,500 shares (Voting Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.5K

0% 3M change

0% 12M change

Total Value Held $545,125

Lawrence Otto Klein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 12 2022	BUY Grant, award, or other acquisition	-	24,500 Added 50.0%	24,500 Voting Common Stock

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

CBO & COO

DYN

Dyne Therapeutics, Inc. Healthcare

Director

LOK